View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
Oscar Haffen Lamm
  • Oscar Haffen Lamm

Aelis: Full data analysis of AEF117 shows effects in a subpopulation

Following preliminary results on its phase 2b trial evaluating AEF117 in CUD, which as a reminder failed to show statistically significant effects across the binary endpoints, which measured the absolute reduction in cannabis consumption, Aelis published the final analysis of the data set and provi

Thijs Berkelder
  • Thijs Berkelder
ING Helpdesk
  • ING Helpdesk

Benelux Morning Notes

Avantium: The final reckoning; Exor: Increasing stake in Philips to 18.7%; IBA: 2H24 preview; Sif Group: Lowers FY25 outlook; UCB: Positive data in TK2d presented at MDA 2025; Vonovia: Positive valuation in 2H24 and good guidance - focus on market dynamics going forwards

ING Helpdesk
  • ING Helpdesk

Benelux Morning Notes

D'Ieteren: 2H24 beat on Auto, 2025 PBT guidance 2-4% below on fin exp, Auto. Sif Group: All eyes on FY25 EBITDA outlook. Staffing: French staffing - Jan better, Feb outlook indicating further improvement

Delphine Brault ... (+2)
  • Delphine Brault
  • Quentin Borie
Delphine Brault ... (+2)
  • Delphine Brault
  • Quentin Borie
Delphine Brault ... (+2)
  • Delphine Brault
  • Quentin Borie
Delphine Brault ... (+2)
  • Delphine Brault
  • Quentin Borie
 PRESS RELEASE

Aelis Farma annonce son calendrier financier pour l’exercice 2025

BORDEAUX, France--(BUSINESS WIRE)-- Regulatory News: Aelis Farma (ISIN : FR0014007ZB4 – Mnémonique : AELIS, éligible PEA-PME), société biopharmaceutique au stade clinique spécialisée dans le développement de traitements pour les maladies du cerveau et périphériques impliquant le récepteur CB1 du système endocannabinoïde, annonce aujourd’hui son calendrier financier indicatif pour l’exercice 2025. Évènement Date de publication* Résultats annuels 2024 Le mardi 1er avril 2025 Assemblée générale annuelle Le mardi 27 mai 2025 Résultats semestriels 2025 Le lundi 22 sep...

Delphine Brault ... (+2)
  • Delphine Brault
  • Quentin Borie

ODDO : 2025 : potentiellement un meilleur cru que 2024

L’année 2025 verra, selon nous, une poursuite de la croissance du CA (5% estimé vs 1.5% en 2024e) et de l’amélioration de la marge (53 pb vs 14 pb en 2024e), à l’exception possible de quelques sociétés (marge optimisée ou risque lié aux hausses des droits de douane). Si quelques thématiques devraient rester inchangées (exposition USA, Green Capex, datacenters, etc), d’autres émergeront (construction, discrete automation) ou accélèreront (semiconducteurs) au cours de l’année. Dans ce contexte, no...

Delphine Brault ... (+2)
  • Delphine Brault
  • Quentin Borie

ODDO : 2025: set to potentially be a better year than 2024

2025 is in our view likely to see sales continue to grow (5% estimated vs 1.5% in 2024e) and margins continue to improve (53bp vs 14bp in 2024e), with the possible exception of a few companies (optimised margins or tariff risk). While some themes are likely to endure (US exposure, green capex, data centres, etc.), others will emerge (construction, discrete automation) or accelerate (semiconductors) over the year. In this context, our Top Picks are Alstom, Assa Abloy, Siemens and SKF. And we upgr...

David Vagman ... (+13)
  • David Vagman
  • CFA
  • Francesca Ferragina
  • Marc Hesselink
  • CFA
  • Marc Zwartsenburg
  • CEFA
  • Quirijn Mulder
  • Reg Watson
  • CFA
  • Stijn Demeester
  • Thymen Rundberg
  • Tijs Hollestelle

ING Benelux Favourites/Aalberts, ASM, Basic-Fit, D'Ieteren, dsm-firmen...

We refresh our ING Benelux Favourites list. We still apply a fundamental bottom up approach in which we select stocks that provide the best (relative) upside within our Benelux coverage universe and these stocks need clear catalysts. Besides this, we screen the ING Benelux coverage on some key investment themes that are topical and which could affect earnings potential and thus a stock's share price performance: (1) impact of Trump's return to the White House and his key topics on the political ...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch